Wuhan General Gr Executives
WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General employs about 700 people. The company is managed by 21 executives with a total tenure of roughly 138 years, averaging almost 6.0 years of service per executive, having 33.33 employees per reported executive. Analysis of Wuhan General's management performance can provide insight into the firm performance.
Ruilong Qi CEO CEO and President Secretary and Director |
Ramy Kamaneh CEO President CEO |
Wuhan |
Wuhan General Management Team Effectiveness
Wuhan General's management efficiency ratios could be used to measure how well Wuhan General manages its routine affairs as well as how well it operates its assets and liabilities.Wuhan General Workforce Comparison
Wuhan General Gr is rated fifth in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 14,228. Wuhan General holds roughly 700 in number of employees claiming about 5% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03. Wuhan General Notable Stakeholders
A Wuhan General stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Wuhan General often face trade-offs trying to please all of them. Wuhan General's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Wuhan General's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ruilong Qi | CEO and President Secretary and Director | Profile | |
Ramy Kamaneh | President CEO | Profile | |
Jie Xu | Chairman of the Board | Profile | |
Juntao Chen | Vice President Vice General Manager - Blower | Profile | |
Yaojun Liu | Independent Director | Profile | |
Qingsong Zheng | Independent Director | Profile | |
Yu Shi | Independent Director | Profile | |
Zhaoqi Huang | Vice General Manager - Turbine, Director | Profile | |
Carol Pan | Principal Officer | Profile | |
Zengke Ge | General Manager | Profile | |
Willem Jonker | Chief Officer | Profile | |
Jeffrey Robinson | Chairman Founder | Profile | |
Anna Morera | Chief Medical Officer | Profile | |
Luka MSc | Director Communication | Profile | |
Huang Zhaoqi | Vice Director | Profile | |
Johann Mcloughlin | Head Design | Profile | |
Shivani Subudhi | Head Marketing | Profile | |
Li Pan | Principal Accounting Officer, Treasurer | Profile | |
Guoliang Liu | IR Contact | Profile | |
Samuel Williams | Head Foods | Profile | |
AAg MSc | Chief Officer | Profile |
About Wuhan General Management Performance
The success or failure of an entity such as Wuhan General Gr often depends on how effective the management is. Wuhan General management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Wuhan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Wuhan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.
The data published in Wuhan General's official financial statements usually reflect Wuhan General's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Wuhan General Gr. For example, before you start analyzing numbers published by Wuhan accountants, it's critical to develop an understanding of what Wuhan General's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Wuhan General's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wuhan General's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Wuhan General's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Wuhan General Gr. Please utilize our Beneish M Score to check the likelihood of Wuhan General's management manipulating its earnings.
Wuhan General Workforce Analysis
Traditionally, organizations such as Wuhan General use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Wuhan General within its industry.Wuhan General Manpower Efficiency
Return on Wuhan General Manpower
Revenue Per Employee | 114.8K | |
Revenue Per Executive | 3.8M | |
Net Loss Per Employee | 15.1K | |
Net Loss Per Executive | 504.3K | |
Working Capital Per Employee | 25.7K | |
Working Capital Per Executive | 857.1K |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Wuhan General Gr information on this page should be used as a complementary analysis to other Wuhan General's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |